Public Services and Procurement Minister Anita Anand said today that Canada is ready to deploy a new COVID vaccine from Johnson & Johnson’s pharmaceutical division, Janssen, once it receives regulatory approval from Health Canada — but she couldn’t say how many shots will be available in the coming weeks.
The U.S. Food and Drug Administration’s vaccines and related biological products advisory committee will meet Friday to review the clinical trial data for this vaccine. A final U.S. decision on issuing emergency use authorization (EUA) could follow as early as this weekend.
The same FDA committee met in early December to review Pfizer’s vaccine and, a day later, the EUA was issued. Later that month, the FDA committee met to review the Moderna vaccine and an EUA was granted the next day.
Health Canada could make the same decision in a matter of days. The U.S. and Canada have been in synch on past COVID-19 vaccine approvals.
A spokesperson for the department said Health Canada “intends to be as aligned as possible with the decisions of our key regulatory partners, once all of the data required to make a decision has been received and reviewed.”
“Health Canada continues to receive data from Janssen,” the spokesperson told CBC News…